Cytochrome P450 2C9 Type II Binding Studies on Quinoline-4-Carboxamide Analogues
- 19 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (24), 8000-8011
- https://doi.org/10.1021/jm8011257
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Characterization of Type II Ligands in CYP2C9 and CYP3A4Journal of Medicinal Chemistry, 2008
- Formation of the Active Species of Cytochrome P450 by Using Iodosylbenzene: A Case for Spin-Selective ReactivityChemistry – A European Journal, 2007
- Visible Spectra of Type II Cytochrome P450-Drug Complexes: Evidence that “Incomplete” Heme Coordination Is CommonDrug Metabolism and Disposition, 2007
- Line-Walking Method for Predicting the Inhibition of P450 Drug MetabolismJournal of Medicinal Chemistry, 2006
- Charge and Substituent Effects on Affinity and Metabolism of Benzbromarone-Based CYP2C19 InhibitorsJournal of Medicinal Chemistry, 2004
- Comparative assessment of a new nonempirical density functional: Molecules and hydrogen-bonded complexesThe Journal of Chemical Physics, 2003
- Ketoconazole-induced conformational changes in the active site of cytochrome P450eryFJournal of Molecular Biology, 2001
- EPR Spectrometry of Cytochrome P450 2B4: Effects of Mutations and Substrate BindingBiochemical and Biophysical Research Communications, 2000
- Stabilization of bound polycyclic aromatic hydrocarbons by a π-cation interactionJournal of Molecular Biology, 2000
- Nature of the type I and II spectral changes in liver microsomesBiochemistry, 1970